ATOS•benzinga•
Atossa Therapeutics: USPTO Grants New Patent Directed To Enteric Oral Formulations Comprising (Z)-endoxifen As Well As Methods Of Treating Subjects With Oral Formulations
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga